PPARG and nephrolithiasis, calcium oxalate: We sought to elucidate the role of imbalanced mitochondrial dynamics in calcium oxalate nephrolithiasis and the ameliorative effect of PPARγ agonist treatment on mitochondrial damage in TECs.